April 14, 2026 · Form 4 insider transaction
Calvin Sandra bought 2,500 shares of Travere Therapeutics, Inc. at $22.40 per share, a transaction worth $56.0K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.